Zhai D, Godoi P, Sergienko E, Dahl R, Chan X, Brown B, Rascon J, Hurder A, Su Y, Chung TD, Jin C, Diaz P, Reed JC. "J Biomol Screen. 2011 Dec"
Overexpression with the anti-apoptotic Bcl-2 loved ones proteins occurs normally in human cancers. Bfl-1 is highly expressed in a few kinds of malignant cells, contributing considerably to tumor mobile survival and chemoresistance. Hence, it would be appealing to possess chemical antagonists of Bfl-1.
To this end, we devised a fluorescence polarization assay (FPA) applying Bfl-1 protein and fluorescein-conjugated Bid BH3 peptide, which was utilized for high-throughput screening of chemical library.
Approximately 66 000 compounds had been screened for your potential to inhibit BH3 peptide binding to Bfl-1, yielding 14 reproducible hits with ?Y50% displacement. Immediately after dose-response analysis and confirmation working with a secondary assay according to time-resolved fluorescence resonance power transfer (TR-FRET), two teams of Bfl-1-specific inhibitors were identified, which includes chloromaleimide and sulfonylpyrimidine sequence compounds.
Fluorescence Polarization Assay (FPA) generated for each from the 6 anti-apoptotic Bcl-2 proteins demonstrated selective binding of both classes of compounds to Bfl-1. Analogs in the sulfonylpyrimidine collection had been synthesized and in contrast with the original strike for Bfl-1 binding by each FPAs and TR-FRET assays.
The ensuing structure-activity relation analysis led for the chemical probe compound CID-2980973 (ML042). Collectively, these findings demonstrate the feasibility of utilizing the HTS assay for discovery of selective chemical inhibitors of Bfl-1.
Guangxitoxin-1E is a specific inhibitor of the Kv current of β-cells, can enhance the glucose-dependent intracellular calcium elevations and increases the glucose-dependent insulin secretion. It is considered as a useful tool for the investigation of type 2 diabetes. Guangxitoxin 1E
回复删除